A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People
NCT06367426
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
DDN-A-0101 (SAD)
DRUG:
DDN-A-0101 (MAD)
DRUG:
Placebo (SAD)
DRUG:
Placebo (MAD)
Sponsor
Pharmacobio